Calcium Ascorbate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB14483 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 16 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | insomnia (disease) | KG + DL |
| 2 | diabetic cataract | KG + DL |
| 3 | craniostenosis cataract | KG + DL |
| 4 | mature cataract | KG + DL |
| 5 | diabetes mellitus type 2 associated cataract | KG + DL |
| 6 | tetanic cataract | KG + DL |
| 7 | immature cataract | KG + DL |
| 8 | cortical cataract | KG + DL |
| 9 | nuclear senile cataract | KG + DL |
| 10 | diabetic retinopathy | KG + DL |
| 11 | senile cataract | KG + DL |
| 12 | severe nonproliferative diabetic retinopathy | KG + DL |
| 13 | antithrombin deficiency type 2 | KG + DL |
| 14 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 15 | heparin cofactor 2 deficiency | KG + DL |
| 16 | thrombophilia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.